Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Transmedics Group, Inc. (TMDX) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Transmedics Group, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1756262.
Total stock buying since 2019: $3,081,828.
Total stock sales since 2019: $157,854,996.
Total stock option exercises since 2019: $16,576,669.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 28,337 | $3,343,234 | 24,512 | $30,782 |
| 2024 | 0 | $0 | 536,774 | $65,936,974 | 425,908 | $10,043,824 |
| 2023 | 0 | $0 | 304,084 | $22,368,338 | 317,952 | $2,690,968 |
| 2022 | 0 | $0 | 418,713 | $18,494,099 | 323,542 | $3,200,124 |
| 2021 | 100,000 | $2,242,500 | 1,134,333 | $37,514,141 | 432,515 | $536,717 |
| 2020 | 0 | $0 | 45,816 | $823,210 | 133,600 | $70,362 |
| 2019 | 51,833 | $839,328 | 500,000 | $9,375,000 | 13,900 | $3,892 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-23 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 3,142 | 16.00 | 50,272 |
| 2023-01-20 | Hassanein Waleed H (President & CEO) | Sale | 6,332 | 65.19 | 412,783 |
| 2023-01-20 | Khayal Tamer I (Chief Commercial Officer) | Sale | 5,558 | 65.21 | 362,437 |
| 2023-01-20 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 5,558 | 16.00 | 88,928 |
| 2023-01-18 | Hassanein Waleed H (President & CEO) | Sale | 1,306 | 65.09 | 85,007 |
| 2023-01-18 | Khayal Tamer I (Chief Commercial Officer) | Sale | 1,300 | 65.11 | 84,643 |
| 2023-01-18 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 1,300 | 16.00 | 20,800 |
| 2023-01-17 | Gordon Stephen (Chief Financial Officer) | Sale | 5,000 | 60.12 | 300,600 |
| 2023-01-17 | Gordon Stephen (Chief Financial Officer) | Option Ex | 5,000 | 16.14 | 80,700 |
| 2023-01-17 | Carey John F (VP of Operations) | Sale | 1,410 | 62.59 | 88,257 |
| 2023-01-17 | Carey John F (VP of Operations) | Option Ex | 1,410 | 38.46 | 54,228 |
| 2023-01-17 | Hassanein Waleed H (President & CEO) | Sale | 7,500 | 64.14 | 481,050 |
| 2022-12-09 | Provost Miriam (VP, Global Regulatory Affairs) | Sale | 3,613 | 59.00 | 213,167 |
| 2022-12-09 | Provost Miriam (VP, Global Regulatory Affairs) | Option Ex | 5,126 | 27.30 | 139,939 |
| 2022-12-01 | Gordon Stephen (Chief Financial Officer) | Sale | 10,000 | 61.73 | 617,250 |
| 2022-12-01 | Gordon Stephen (Chief Financial Officer) | Option Ex | 10,000 | 16.14 | 161,400 |
| 2022-12-01 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 11,051 | 2.21 | 24,422 |
| 2022-11-23 | Lovell Stephanie (Director) | Sale | 16,971 | 59.50 | 1,009,773 |
| 2022-11-23 | Lovell Stephanie (Director) | Option Ex | 16,971 | 47.82 | 811,551 |
| 2022-11-22 | Lovell Stephanie (Director) | Sale | 14,700 | 58.01 | 852,672 |
| 2022-11-22 | Lovell Stephanie (Director) | Option Ex | 14,700 | 37.04 | 544,488 |
| 2022-11-15 | Hassanein Waleed H (President & CEO) | Sale | 14,483 | 60.13 | 870,862 |
| 2022-11-15 | Khayal Tamer I (Chief Commercial Officer) | Sale | 4,254 | 60.06 | 255,495 |
| 2022-11-15 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 4,254 | 2.21 | 9,401 |
| 2022-11-11 | Hassanein Waleed H (President & CEO) | Sale | 2,748 | 60.03 | 164,962 |
| 2022-11-11 | Khayal Tamer I (Chief Commercial Officer) | Sale | 2,702 | 60.03 | 162,201 |
| 2022-11-11 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 2,702 | 2.21 | 5,971 |
| 2022-11-10 | Weill David (Director) | Sale | 21,645 | 56.00 | 1,212,120 |
| 2022-11-10 | Weill David (Director) | Option Ex | 21,645 | 16.00 | 346,320 |
| 2022-11-01 | Carey John F (VP of Operations) | Sale | 3,000 | 49.22 | 147,660 |
| 2022-11-01 | Carey John F (VP of Operations) | Option Ex | 3,000 | .28 | 840 |
| 2022-09-02 | Provost Miriam (VP, Global Regulatory Affairs) | Option Ex | 2,600 | 3.22 | 8,372 |
| 2022-09-01 | Carey John F (VP of Operations) | Sale | 3,000 | 51.05 | 153,135 |
| 2022-09-01 | Carey John F (VP of Operations) | Option Ex | 3,000 | 2.21 | 6,630 |
| 2022-08-24 | Hassanein Waleed H (President & CEO) | Sale | 3,591 | 50.13 | 180,016 |
| 2022-08-23 | Hassanein Waleed H (President & CEO) | Sale | 16,409 | 50.04 | 821,106 |
| 2022-08-12 | Hassanein Waleed H (President & CEO) | Sale | 7,000 | 48.00 | 336,000 |
| 2022-08-11 | Hassanein Waleed H (President & CEO) | Sale | 12,929 | 46.74 | 604,301 |
| 2022-08-08 | Gordon Stephen (Chief Financial Officer) | Sale | 10,000 | 48.09 | 480,900 |
| 2022-08-08 | Gordon Stephen (Chief Financial Officer) | Option Ex | 10,000 | 2.21 | 22,100 |
| 2022-08-05 | Hassanein Waleed H (President & CEO) | Sale | 20,000 | 45.13 | 902,600 |
| 2022-08-05 | Khayal Tamer I (Chief Commercial Officer) | Sale | 20,000 | 45.12 | 902,400 |
| 2022-08-05 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 10,000 | 2.21 | 22,100 |
| 2022-08-01 | Carey John F (VP of Operations) | Sale | 3,000 | 41.08 | 123,249 |
| 2022-08-01 | Carey John F (VP of Operations) | Option Ex | 3,000 | 2.21 | 6,630 |
| 2022-07-29 | Carey John F (VP of Operations) | Sale | 4,000 | 40.01 | 160,040 |
| 2022-07-29 | Carey John F (VP of Operations) | Option Ex | 4,000 | 7.75 | 30,980 |
| 2022-07-29 | Khayal Tamer I (Chief Commercial Officer) | Sale | 13,504 | 40.01 | 540,295 |
| 2022-07-29 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 13,504 | 1.25 | 16,812 |
| 2022-07-29 | Tobin James R (Director) | Sale | 48,515 | 39.98 | 1,939,629 |
| 2022-07-20 | Carey John F (VP of Operations) | Sale | 1,500 | 34.57 | 51,855 |
| 2022-07-20 | Carey John F (VP of Operations) | Option Ex | 1,500 | 14.71 | 22,065 |
| 2022-07-11 | Carey John F (VP of Operations) | Sale | 1,500 | 32.98 | 49,469 |
| 2022-07-11 | Carey John F (VP of Operations) | Option Ex | 1,500 | 16.14 | 24,210 |
| 2022-07-05 | Gordon Stephen (Chief Financial Officer) | Sale | 10,000 | 35.00 | 350,000 |
| 2022-07-05 | Gordon Stephen (Chief Financial Officer) | Option Ex | 10,000 | 2.21 | 22,100 |
| 2022-07-05 | Khayal Tamer I (Chief Commercial Officer) | Sale | 13,504 | 35.06 | 473,450 |
| 2022-07-05 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 13,504 | .28 | 3,781 |
| 2022-07-05 | Tobin James R (Director) | Sale | 48,515 | 35.00 | 1,698,025 |
| 2022-06-28 | Carey John F (VP of Operations) | Sale | 2,724 | 32.87 | 89,537 |
| 2022-06-28 | Carey John F (VP of Operations) | Option Ex | 2,724 | .28 | 762 |
| 2022-06-27 | Carey John F (VP of Operations) | Sale | 3,320 | 32.59 | 108,198 |
| 2022-06-27 | Carey John F (VP of Operations) | Option Ex | 3,320 | .28 | 929 |
| 2022-06-24 | Carey John F (VP of Operations) | Sale | 2,956 | 32.57 | 96,276 |
| 2022-06-24 | Carey John F (VP of Operations) | Option Ex | 2,956 | .28 | 827 |
| 2022-06-01 | Carey John F (VP of Operations) | Sale | 1,500 | 28.32 | 42,472 |
| 2022-06-01 | Carey John F (VP of Operations) | Option Ex | 1,500 | .28 | 420 |
| 2022-05-04 | Carey John F (VP of Operations) | Sale | 1,500 | 25.31 | 37,965 |
| 2022-05-04 | Carey John F (VP of Operations) | Option Ex | 1,500 | .28 | 420 |
| 2022-05-04 | Tobin James R (Director) | Sale | 48,516 | 29.94 | 1,452,569 |
| 2022-04-01 | Carey John F (VP of Operations) | Sale | 1,500 | 26.85 | 40,275 |
| 2022-04-01 | Carey John F (VP of Operations) | Option Ex | 1,500 | .28 | 420 |
| 2022-03-28 | Carey John F (VP of Operations) | Sale | 4,500 | 25.01 | 112,545 |
| 2022-03-28 | Carey John F (VP of Operations) | Option Ex | 4,500 | 6.21 | 27,945 |
| 2022-01-06 | Hassanein Waleed H (President & CEO) | Option Ex | 122,371 | .28 | 34,263 |
| 2021-12-23 | Provost Miriam (VP of US Regulatory & FDA Rel.) | Option Ex | 884 | 3.22 | 2,846 |
| 2021-11-29 | Kania Edwin M Jr (Director) | Buy | 100,000 | 22.43 | 2,242,500 |
| 2021-11-01 | Carey John F (VP of Operations) | Sale | 1,680 | 28.16 | 47,308 |
| 2021-11-01 | Carey John F (VP of Operations) | Option Ex | 1,680 | 2.21 | 3,712 |
| 2021-10-01 | Carey John F (VP of Operations) | Sale | 1,680 | 32.25 | 54,180 |
| 2021-10-01 | Carey John F (VP of Operations) | Option Ex | 1,680 | 2.21 | 3,712 |
| 2021-09-15 | Provost Miriam (VP of US Regulatory & FDA Rel.) | Sale | 3,877 | 31.34 | 121,505 |
| 2021-09-15 | Provost Miriam (VP of US Regulatory & FDA Rel.) | Option Ex | 5,625 | 16.14 | 90,787 |
| 2021-09-07 | Gordon Stephen (Chief Financial Officer) | Sale | 10,000 | 35.00 | 350,000 |
| 2021-09-07 | Gordon Stephen (Chief Financial Officer) | Option Ex | 10,000 | .67 | 6,700 |
| 2021-09-07 | Khayal Tamer I (Chief Commercial Officer) | Sale | 3,941 | 35.08 | 138,250 |
| 2021-09-07 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 3,941 | .28 | 1,103 |
| 2021-09-01 | Carey John F (VP of Operations) | Sale | 1,680 | 32.07 | 53,877 |
| 2021-09-01 | Carey John F (VP of Operations) | Option Ex | 1,680 | 2.21 | 3,712 |
| 2021-08-30 | Sullivan John F (VP of Quality & Engineering) | Option Ex | 3,200 | .28 | 896 |
| 2021-08-02 | Carey John F (VP of Operations) | Sale | 1,680 | 28.33 | 47,594 |
| 2021-08-02 | Carey John F (VP of Operations) | Option Ex | 1,680 | 2.21 | 3,712 |
| 2021-07-30 | Provost Miriam (VP of US Regulatory & FDA Rel.) | Option Ex | 2,206 | 3.22 | 7,103 |
| 2021-07-15 | Gordon Stephen (Chief Financial Officer) | Sale | 10,000 | 35.00 | 350,000 |
| 2021-07-15 | Gordon Stephen (Chief Financial Officer) | Option Ex | 10,000 | .67 | 6,700 |
| 2021-07-15 | Khayal Tamer I (Chief Commercial Officer) | Sale | 5,152 | 35.10 | 180,835 |
| 2021-07-15 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 5,152 | .28 | 1,442 |
| 2021-07-01 | Carey John F (VP of Operations) | Sale | 1,680 | 33.83 | 56,826 |
| 2021-07-01 | Carey John F (VP of Operations) | Option Ex | 1,680 | 2.21 | 3,712 |
| 2021-05-03 | Carey John F (VP of Operations) | Sale | 1,680 | 28.55 | 47,955 |
| 2021-05-03 | Carey John F (VP of Operations) | Option Ex | 1,680 | 9.18 | 15,414 |
| 2021-04-07 | Sullivan John F (VP of Quality & Engineering) | Sale | 15,000 | 36.70 | 550,455 |
| 2021-04-07 | Sullivan John F (VP of Quality & Engineering) | Option Ex | 15,000 | 9.18 | 137,625 |
| 2021-04-05 | Carey John F (VP of Operations) | Sale | 3,360 | 37.44 | 125,798 |
| 2021-04-05 | Carey John F (VP of Operations) | Option Ex | 3,360 | 16.14 | 54,230 |
| 2021-04-05 | Hassanein Waleed H (President & CEO) | Option Ex | 125,000 | .28 | 35,000 |
| 2021-04-01 | Hassanein Waleed H (President & CEO) | Sale | 60,000 | 41.00 | 2,460,180 |
| 2021-03-15 | Gordon Stephen (Chief Financial Officer) | Sale | 10,000 | 39.81 | 398,100 |
| 2021-03-15 | Gordon Stephen (Chief Financial Officer) | Option Ex | 10,000 | .67 | 6,700 |
| 2021-03-11 | Carey John F (VP of Operations) | Sale | 3,200 | 37.50 | 120,000 |
| 2021-03-10 | Hassanein Waleed H (President & CEO) | Sale | 35,007 | 34.20 | 1,197,414 |
| 2021-03-10 | Hassanein Waleed H (President & CEO) | Option Ex | 35,007 | 2.21 | 77,365 |
| 2021-03-08 | Khayal Tamer I (Chief Commercial Officer) | Sale | 20,000 | 32.00 | 640,000 |
| 2021-03-08 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 20,000 | .28 | 5,600 |
| 2021-03-05 | Khayal Tamer I (Chief Commercial Officer) | Sale | 20,000 | 30.77 | 615,400 |
| 2021-03-05 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 20,000 | .34 | 6,700 |
| 2021-02-16 | Gordon Stephen (Chief Financial Officer) | Sale | 10,000 | 31.33 | 313,300 |
| 2021-02-16 | Gordon Stephen (Chief Financial Officer) | Option Ex | 10,000 | .67 | 6,700 |
| 2021-02-09 | Riva Capital Management Iii, Llc (10% Owner) | Sale | 786,664 | 33.32 | 26,208,497 |
| 2021-02-09 | Sullivan John F (VP of Quality & Engineering) | Sale | 8,600 | 33.48 | 287,928 |
| 2021-02-09 | Sullivan John F (VP of Quality & Engineering) | Option Ex | 8,600 | .28 | 2,408 |
| 2021-02-09 | Tobin James R (Director) | Sale | 10,168 | 33.49 | 340,526 |
| 2021-02-08 | Riva Capital Management Iii, Llc (10% Owner) | Sale | 88,483 | 26.24 | 2,321,705 |
| 2021-02-08 | Gordon Stephen (Chief Financial Officer) | Sale | 10,000 | 25.01 | 250,100 |
| 2021-02-08 | Gordon Stephen (Chief Financial Officer) | Option Ex | 1,429 | .67 | 957 |
| 2021-01-19 | Sullivan John F (VP of Quality & Engineering) | Sale | 9,617 | 22.12 | 212,728 |
| 2021-01-19 | Sullivan John F (VP of Quality & Engineering) | Option Ex | 9,617 | .39 | 3,750 |
| 2021-01-05 | Hassanein Waleed H (President & CEO) | Option Ex | 123,414 | .39 | 48,131 |
| 2021-01-04 | Gordon Stephen (Chief Financial Officer) | Sale | 1,184 | 20.00 | 23,680 |
| 2020-12-31 | Gordon Stephen (Chief Financial Officer) | Sale | 8,816 | 20.00 | 176,320 |
| 2020-12-21 | Sullivan John F (VP of Quality & Engineering) | Sale | 1,000 | 17.99 | 17,990 |
| 2020-12-16 | Sullivan John F (VP of Quality & Engineering) | Option Ex | 1,000 | .39 | 390 |
| 2020-12-15 | Sullivan John F (VP of Quality & Engineering) | Sale | 3,000 | 16.63 | 49,890 |
| 2020-12-15 | Sullivan John F (VP of Quality & Engineering) | Option Ex | 3,000 | .39 | 1,170 |
| 2020-12-11 | Provost Miriam (VP of US Regulatory & FDA Rel.) | Option Ex | 4,600 | 3.22 | 14,812 |
| 2020-09-01 | Carey John F (VP of Operations) | Sale | 2,000 | 17.59 | 35,180 |
| 2020-09-01 | Carey John F (VP of Operations) | Option Ex | 2,000 | .39 | 780 |
| 2020-08-03 | Carey John F (VP of Operations) | Sale | 2,000 | 18.77 | 37,540 |
| 2020-08-03 | Carey John F (VP of Operations) | Option Ex | 2,000 | 2.21 | 4,420 |
| 2020-07-01 | Carey John F (VP of Operations) | Sale | 2,000 | 17.32 | 34,650 |
| 2020-07-01 | Carey John F (VP of Operations) | Option Ex | 2,000 | 1.30 | 2,600 |
| 2020-06-01 | Carey John F (VP of Operations) | Sale | 2,000 | 13.21 | 26,420 |
| 2020-06-01 | Carey John F (VP of Operations) | Option Ex | 2,000 | .39 | 780 |
| 2020-05-01 | Carey John F (VP of Operations) | Sale | 2,000 | 17.25 | 34,490 |
| 2020-05-01 | Carey John F (VP of Operations) | Option Ex | 2,000 | .39 | 780 |
| 2020-04-27 | Gordon Stephen (Chief Financial Officer) | Sale | 9,900 | 18.00 | 178,200 |
| 2020-04-22 | Gordon Stephen (Chief Financial Officer) | Sale | 100 | 18.00 | 1,800 |
| 2020-04-07 | Carey John F (VP of Operations) | Sale | 2,000 | 13.10 | 26,200 |
| 2020-04-07 | Carey John F (VP of Operations) | Option Ex | 2,000 | .39 | 780 |
| 2020-03-27 | Hassanein Waleed H (President & CEO) | Option Ex | 100,000 | .39 | 39,000 |
| 2020-03-02 | Carey John F (VP of Operations) | Sale | 2,000 | 15.55 | 31,110 |
| 2020-03-02 | Carey John F (VP of Operations) | Option Ex | 2,000 | .39 | 780 |
| 2020-02-03 | Carey John F (VP of Operations) | Sale | 2,000 | 17.71 | 35,420 |
| 2020-02-03 | Carey John F (VP of Operations) | Option Ex | 2,000 | .39 | 780 |
| 2020-01-21 | Khayal Tamer I (Chief Commercial Officer) | Sale | 5,000 | 20.02 | 100,100 |
| 2020-01-21 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 5,000 | .39 | 1,950 |
| 2020-01-17 | Carey John F (VP of Operations) | Option Ex | 2,000 | .28 | 560 |
| 2020-01-02 | Carey John F (VP of Operations) | Sale | 2,000 | 18.95 | 37,900 |
| 2020-01-02 | Carey John F (VP of Operations) | Option Ex | 2,000 | .39 | 780 |
| 2019-12-09 | Lung Biotechnology Pbc (10% Owner) | Sale | 500,000 | 18.75 | 9,375,000 |
| 2019-11-15 | Sullivan John F (VP of Quality & Engineering) | Option Ex | 1,400 | .28 | 392 |
| 2019-11-15 | Carey John F (VP of Operations) | Option Ex | 1,200 | .28 | 336 |
| 2019-11-11 | Weill David (Director) | Buy | 10,000 | 17.00 | 170,000 |
| 2019-08-09 | Hassanein Waleed H (President & CEO) | Option Ex | 6,000 | .28 | 1,680 |
| 2019-08-09 | Khayal Tamer I (Chief Commercial Officer) | Option Ex | 1,300 | .28 | 364 |
| 2019-06-13 | Hassanein Waleed H (President & CEO) | Option Ex | 4,000 | .28 | 1,120 |
| 2019-05-06 | Basile Edward M (Director) | Buy | 8,500 | 16.00 | 136,000 |
| 2019-05-06 | Kania Edwin M Jr (Director) | Buy | 33,333 | 16.00 | 533,328 |
Insider trading activities including stock purchases, stock sales, and option exercises of TMDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Transmedics Group, Inc. (symbol TMDX, CIK number 1756262) see the Securities and Exchange Commission (SEC) website.